ArticleFrontiers in pharmacology2022
Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series.
Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The price and affordability of essential medicines, progress and regional distribution in China: a systematic review.Frontiers in pharmacology · 2023Pooled it
- Drug price trends, regional disparities, and supply shortages under China's National Volume-Based Procurement: a nationwide analysis (2018-2024).BMC health services research · 2026Article
- Changes in the burden of lower respiratory infections in China before and after the implementation of the national centralized drug procurement policy.Infectious medicine · 2026Article
- The impact of China's National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysis.Journal of pharmaceutical policy and practice · 2026Article
- Trends and determinants of hospitalization costs for umbilical hernia: a 13-year retrospective analysis from 2012 to 2024.Frontiers in surgery · 2026Article
- The impacts of the national volume-based procurement policy on the chronic disease medication market in China's public hospitals: a case study of medications for diabetes.BMC health services research · 2025Article
- Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia.Journal of health, population, and nutrition · 2025Article
- Technological and industrial trends in China's pharmaceutical sector.Frontiers in pharmacology · 2025Review
- Cost shifting or cost cutting by hospitals as a response to reimbursement reform? The case of diagnosis-related groups (DRG) scheme in China.Frontiers in public health · 2025Article
- Healthcare professionals' knowledge, attitudes, and practices regarding China's National Centralized Drug Procurement policy: a cross-sectional study in Shaanxi Province.Frontiers in public health · 2025Article
- Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors.PloS one · 2025Article
- Impact of China's National Volume-Based Drug Procurement: A Multilevel Interrupted Time Series Analysis on Medical Expenditures in Hypertensive Patients.International journal of health policy and management · 2025Article
- Impact of DRG policy on the performance of tertiary hospital inpatient services in Chongqing, China: an interrupted time series study, 2020-2023.Frontiers in public health · 2025Article
- Anticoagulants utilization in eight hospitals within the Luzhou region from 2019 to 2023.PloS one · 2025Article
- Increased consumption of cardiovascular drugs under volume-based procurement (VBP) policy: demand release or assessment inducing?Health research policy and systems · 2024Article
- Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China.BMC public health · 2024Article
- Research on the improvement mechanism of value-based healthcare objectives in pharmaceutical group procurement.Heliyon · 2024Article
- The impact of Chinese volume-based procurement on pharmaceutical market concentration.Frontiers in pharmacology · 2024Article
- Effect of China national centralized drug procurement policy on anticoagulation selection and hemorrhage events in patients with AF in Suining.Frontiers in pharmacology · 2024Article
- The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis.International journal for equity in health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.